What is the appropriate dosage and administration schedule of Mixtard (biphasic isophane insulin) for a patient with diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mixtard Dosing and Administration for Diabetes Management

For a patient requiring Mixtard (biphasic isophane insulin), start with 0.3-0.5 units/kg/day divided into two doses given 30 minutes before breakfast and dinner, with two-thirds of the total daily dose given in the morning and one-third in the evening. 1

Initial Dosing Strategy

Type 2 Diabetes Patients

  • Begin with 0.3 units/kg/day as augmentation therapy if the patient has some residual insulin secretion and is on oral medications 1
  • For more severe hyperglycemia (HbA1c ≥10%), use replacement therapy starting at 0.6-1.0 units/kg/day 1
  • Divide the total daily dose with approximately two-thirds given before breakfast and one-third before dinner 2

Type 1 Diabetes Patients

  • Total daily insulin requirements typically range from 0.4-1.0 units/kg/day 3
  • For metabolically stable patients, 0.5 units/kg/day is the typical starting point 3
  • Mixtard can be given as two or three injections per day, though basal-bolus regimens with separate insulins are generally preferred 4

Administration Timing

  • Administer Mixtard 30 minutes before meals to allow the short-acting component to begin working when food is consumed 2
  • The morning dose should be given 30 minutes before breakfast 2
  • The evening dose should be given 30 minutes before dinner 2

Dose Titration Protocol

  • Increase the dose by 2-4 units every 3 days based on fasting and pre-dinner glucose readings 3
  • Target fasting plasma glucose of 80-130 mg/dL (4.4-7.2 mmol/L) 3
  • If hypoglycemia occurs without clear cause, reduce the corresponding dose by 10-20% immediately 3

Critical Monitoring Requirements

  • Check fasting blood glucose daily during titration 3
  • Monitor pre-dinner glucose to assess morning dose adequacy 3
  • Assess HbA1c every 3 months during intensive titration 3

Foundation Therapy Considerations

  • Continue metformin at maximum tolerated dose (up to 2000-2550 mg daily) when using Mixtard, as this combination reduces insulin requirements and weight gain 1, 4
  • Do not abruptly discontinue oral medications when starting insulin due to risk of rebound hyperglycemia 4

Special Population Adjustments

Elderly or High-Risk Patients

  • Start with lower doses of 0.1-0.25 units/kg/day for patients over 65 years, those with renal impairment, or poor oral intake 3
  • Reduce total daily dose by 20% when transitioning from home insulin regimen to hospital setting if on high doses (≥0.6 units/kg/day) 3

Renal Impairment

  • For CKD Stage 5 with type 2 diabetes, reduce total daily insulin dose by 50% 3
  • For CKD Stage 5 with type 1 diabetes, reduce total daily insulin dose by 35-40% 3

Critical Pitfalls to Avoid

  • Never use premixed insulin like Mixtard in hospitalized patients, as randomized trials show unacceptably high rates of hypoglycemia compared to basal-bolus regimens 3
  • Do not rely on sliding scale insulin alone—always use scheduled insulin doses 5, 3
  • Avoid giving any insulin at bedtime without the evening meal, as this significantly increases nocturnal hypoglycemia risk 3
  • Do not continue escalating Mixtard doses beyond 1.0 units/kg/day without reassessing the regimen, as this may indicate need for transition to basal-bolus therapy 3

When to Transition Away from Mixtard

  • Consider switching to separate basal and prandial insulins when total daily dose exceeds 0.5-1.0 units/kg/day without achieving glycemic targets, as this allows more flexible dosing and better glycemic control 3
  • Basal-bolus therapy provides superior glycemic control with reduced hospital complications compared to premixed insulin regimens 3
  • For patients with type 1 diabetes, multiple daily injections with separate basal and prandial insulins are generally preferred over premixed formulations 4

References

Research

Insulin management of type 2 diabetes mellitus.

American family physician, 2011

Research

Insulin therapy in type II diabetes.

Diabetes care, 1993

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.